Cargando…
Remodeling of cellular cytoskeleton by the acid sphingomyelinase/ceramide pathway
The chemotherapeutic agent cisplatin is widely used in treatment of solid tumors. In breast cancer cells, cisplatin produces early and marked changes in cell morphology and the actin cytoskeleton. These changes manifest as loss of lamellipodia/filopodia and appearance of membrane ruffles. Furthermor...
Autores principales: | Zeidan, Youssef H., Jenkins, Russell W., Hannun, Yusuf A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2315679/ https://www.ncbi.nlm.nih.gov/pubmed/18426979 http://dx.doi.org/10.1083/jcb.200705060 |
Ejemplares similares
-
A new twist to the emerging functions of ceramides in cancer: novel role for platelet acid sphingomyelinase in cancer metastasis
por: Hannun, Yusuf A, et al.
Publicado: (2015) -
Lack of Acid Sphingomyelinase Induces Age-Related Retinal Degeneration
por: Wu, Bill X., et al.
Publicado: (2015) -
Identification and Biochemical Characterization of an Acid Sphingomyelinase-Like Protein from the Bacterial Plant Pathogen Ralstonia solanacearum that Hydrolyzes ATP to AMP but Not Sphingomyelin to Ceramide
por: Airola, Michael V., et al.
Publicado: (2014) -
Alterations of the Ceramide Metabolism in the Peri-Infarct Cortex Are Independent of the Sphingomyelinase Pathway and Not Influenced by the Acid Sphingomyelinase Inhibitor Fluoxetine
por: Brunkhorst, R., et al.
Publicado: (2015) -
Neutral sphingomyelinase-2, acid sphingomyelinase, and ceramide levels in COPD patients compared to controls
por: Lea, Simon R, et al.
Publicado: (2016)